Subcutaneous C1-Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1-INH-HAE

Shimalee Andarawewa; Emel Aygören-Pürsün

doi:10.1002/ccr3.3743

Subcutaneous C1-Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1-INH-HAE

Clin Case Rep. 2021 Feb 6;9(3):1273-1275. doi: 10.1002/ccr3.3743. eCollection 2021 Mar.

Authors

Shimalee Andarawewa¹, Emel Aygören-Pürsün¹

Affiliation

¹ Hereditary Angioedema Center Department of Children and Adolescents University Hospital Goethe University Frankfurt am Main Frankfurt Germany.

Abstract

Subcutaneous plasma-derived human C1-Inhibitor concentrate (pdC1INH) may be safe and effective for long-term prophylaxis during pregnancy and lactation in hereditary angioedema patients.

Keywords: C1‐inhibitor concentrate; hereditary angioedema; lactation; pregnancy; prophylaxis.

Publication types

Case Reports